Taken together, it is likely that multiple mechanism contribute to the effects of pirfenidone and that inhibition of non-canonical TGF-β-mediated signaling pathways plays a role in the anti-fibrotic and anti-cancer effects. Here, TGFB1 is linked to cancer.